These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22397034)

  • 1. Varying clinical features of Turkish Kawasaki disease patients.
    Gülhan B; Kesici S; Beken S; Cilsal E; Kale G; Alehan D; Kara A; Ozen S
    Turk J Pediatr; 2012; 54(1):1-6. PubMed ID: 22397034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey.
    Ozdemir H; Ciftçi E; Tapisiz A; Ince E; Tutar E; Atalay S; Dogru U
    J Trop Pediatr; 2010 Aug; 56(4):260-2. PubMed ID: 20007257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, treatment and outcome of Kawasaki disease in an Australian tertiary setting: a review of three years experience.
    Singh-Grewal D; Wong M; Isaacs D
    J Paediatr Child Health; 2005; 41(9-10):495-9. PubMed ID: 16150066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki disease: part I. Diagnosis, clinical features, and pathogenesis.
    Bayers S; Shulman ST; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):501.e1-11; quiz 511-2. PubMed ID: 24034379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroid treatment of refractory Kawasaki disease.
    Lang BA; Yeung RS; Oen KG; Malleson PN; Huber AM; Riley M; Ebbeson R; Ramsey SE; Laxer RM; Silverman ED; McCrindle BW; Ratnapalan S; Feldman BM
    J Rheumatol; 2006 Apr; 33(4):803-9. PubMed ID: 16583481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease in central area of Northeast Thailand.
    Panamonta M; Chaikitpinyo A; Durongpisitkul K; Somchit S; Petcharatana S; Wongswadiwat Y; Kosalaraksa P; Lumbiganon P
    J Med Assoc Thai; 2004 Aug; 87(8):887-90. PubMed ID: 15471291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular involvement in Kawasaki disease.
    Narayanan SN; Ahamed MZ; Safia M
    Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations.
    Kubota M; Usami I; Yamakawa M; Tomita Y; Haruta T
    J Paediatr Child Health; 2008 Jun; 44(6):359-62. PubMed ID: 18476929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of diagnosis].
    Ogata S; Ishii M
    Nihon Rinsho; 2008 Feb; 66(2):301-6. PubMed ID: 18260329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of children with Kawasaki disease in Istanbul: a retrospective follow-up study.
    Kayiran SM; Dindar A; Gurakan B
    Clinics (Sao Paulo); 2010; 65(12):1261-5. PubMed ID: 21340213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and classification of Kawasaki disease.
    Sánchez-Manubens J; Bou R; Anton J
    J Autoimmun; 2014; 48-49():113-7. PubMed ID: 24485156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kawasaki disease with severe cardiac sequelae: lessons from recent New Zealand experience.
    Wilson N; Heaton P; Calder L; Nicholson R; Stables S; Gavin R
    J Paediatr Child Health; 2004; 40(9-10):524-9. PubMed ID: 15367145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kawasaki disease. A report of 50 cases].
    González Pascual E; Villanueva Lamas J; Ros Viladoms J; Pons Odena M; Ruiz García-Diego S
    An Esp Pediatr; 1999 Jan; 50(1):39-43. PubMed ID: 10083641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage activation syndrome in the acute phase of Kawasaki disease.
    Latino GA; Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):527-31. PubMed ID: 20485197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P; Ausili E; Schiavino A; Angelone DF; Focarelli B; De Rosa G; Ranno O
    Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX; Gong FQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct; 10(5):617-9. PubMed ID: 18947484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    Pediatr Allergy Immunol; 2010 May; 21(3):515-21. PubMed ID: 20546528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kawasaki disease in Greek children: a retrospective study.
    Alexopoulos A; Vekiou A; Lycopoulou L; Tavena A; Lagona E; Kakourou T
    J Eur Acad Dermatol Venereol; 2013 May; 27(5):580-8. PubMed ID: 22360836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.